Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing ...

CI Financial (TSX:CIX:CA) (OTCPK:CIXXF) received an interim order from the Ontario Superior Court of Justice that authorizes, ...

Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug ...

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of ...

CI Financial receives an interim court order concerning the transaction under which CI shares will be acquired by an ...

The deal counter is buzzing with new funding rounds across sectors. This and more in today’s ETtech Morning Dispatch.

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseasesLed by expert R&D ...

The last round in 2021 valued the healthcare technology firm at $3.2 billion, more than doubling its valuation from $1.3 ...

Key Points - Sovereign-related investors, more commonly referred to as sovereign wealth funds, have increasingly made the Middle East ...